Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy

被引：5
|
作者：
Tenorio, AR [1 ]
Irlanda, IE [1 ]
Narkiewicz, E [1 ]
Smith, KY [1 ]
Kessler, HA [1 ]
Sha, BE [1 ]
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA
来源：
AIDS | 2000年 / 14卷 / 10期
关键词：
D O I：
10.1097/00002030-200007070-00031
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1470 / 1471
页数：2
相关论文
共 50 条
  • [1] Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults
    Saag, MS
    Sonnerborg, A
    Torres, RA
    Lancaster, D
    Gazzard, BG
    Schooley, RT
    Romero, C
    Kelleher, D
    Spreen, W
    LaFon, S
    AIDS, 1998, 12 (16) : F203 - F209
  • [2] Abacavir plus efavirenz plus background combination therapy as a salvage regimen in HIV-infected individuals:: efficacy and safety after 48 weeks
    Herhaus, C
    Wasmuth, JC
    Römer, K
    Salzberger, B
    Schliefer, K
    Rockstroh, JK
    AIDS, 2000, 14 : S39 - S39
  • [3] The efficacy and tolerance of antiretroviral combination containing efavirenz (stocrin) in HIV-infected children
    Petrea, S
    Iosipenco, M
    Popa, M
    Tudor, AM
    Jugulete, G
    Darasteanu, L
    Duma, D
    Luminos, M
    Mardarescu, M
    Mantescu, R
    Gheorghe, E
    Petre, CA
    Streinu, C
    Fedorovici, E
    AIDS, 2000, 14 : S78 - S78
  • [4] Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks
    Wasmuth, JC
    Herhaus, C
    Römer, K
    Salzberger, B
    Kaiser, R
    Schliefer, K
    Voigt, E
    Rockstroh, JK
    AIDS, 2002, 16 (07) : 1077 - 1078
  • [5] SAFETY OF CONTINUING COMBINATION ANTIRETROVIRAL THERAPY DURING CHEMOTHERAPY IN HIV-INFECTED PATIENTS WITH MALIGNANCIES
    Nakamura, A.
    Kojima, Y.
    Kogure, Y.
    Kitagawa, C.
    Yokomaku, Y.
    Nagai, H.
    Saka, H.
    ANNALS OF ONCOLOGY, 2013, 24
  • [6] Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen
    Cozzi-Lepri, Alessandro
    Phillips, Andrew N.
    Ruiz, Lidia
    Clotet, Bonaventura
    Loveday, Clive
    Kjaer, Jesper
    Mens, Helene
    Clumeck, Nathan
    Viksna, Ludmila
    Antunes, Francisco
    Machala, Ladislav
    Lundgren, Jens D.
    AIDS, 2007, 21 (06) : 721 - 732
  • [7] Costs associated with combination antiretroviral therapy in HIV-infected patients
    Yazdanpanah, Y
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) : 558 - 561
  • [8] Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women
    Cohan, Deborah
    Natureeba, Paul
    Koss, Catherine A.
    Plenty, Albert
    Luwedde, Flavia
    Mwesigwa, Julia
    Ades, Veronica
    Charlebois, Edwin D.
    Gandhi, Monica
    Clark, Tamara D.
    Nzarubara, Bridget
    Achan, Jane
    Ruel, Theodore
    Kamya, Moses R.
    Havlir, Diane V.
    AIDS, 2015, 29 (02) : 183 - 191
  • [9] Antiretroviral therapy of HIV-infected patients
    Gölz, J
    MEDIZINISCHE WELT, 1999, 50 (06): : 223 - 229
  • [10] Evaluation of the Efficacy and Safety of Changes in Antiretroviral Regimens for HIV-infected Patients
    Tanaka, Hiroyuki
    Wada, Tatsuhiko
    Takayama, Yoko
    Matsumoto, Keisuke
    Atsuda, Koichiro
    Satoh, Mitsutoshi
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (03): : 316 - 323
12345